HUP0002628A2 - Pharmaceutical combinations for treating diabetes - Google Patents

Pharmaceutical combinations for treating diabetes

Info

Publication number
HUP0002628A2
HUP0002628A2 HU0002628A HUP0002628A HUP0002628A2 HU P0002628 A2 HUP0002628 A2 HU P0002628A2 HU 0002628 A HU0002628 A HU 0002628A HU P0002628 A HUP0002628 A HU P0002628A HU P0002628 A2 HUP0002628 A2 HU P0002628A2
Authority
HU
Hungary
Prior art keywords
treating diabetes
pharmaceutical combinations
pharmaceutical
combinations
diabetes
Prior art date
Application number
HU0002628A
Other languages
English (en)
Inventor
Szilvassy Zoltan Dr
Nemeth Jozsef Dr
Tosaki Arpad Dr
Ferdinandy Peter Dr
Hernadi Ferenc Dr
Kovacs Peter Dr
Pankucsi Csaba Dr
Original Assignee
Keri Pharma Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keri Pharma Kft filed Critical Keri Pharma Kft
Priority to HU0002628A priority Critical patent/HUP0002628A2/hu
Publication of HU0002628D0 publication Critical patent/HU0002628D0/hu
Priority to CA002415392A priority patent/CA2415392A1/en
Priority to HU0700127A priority patent/HU227386B1/hu
Priority to AU2001276571A priority patent/AU2001276571A1/en
Priority to AT01954229T priority patent/ATE400298T1/de
Priority to EP01954229A priority patent/EP1303304B1/en
Priority to JP2002511728A priority patent/JP2004503585A/ja
Priority to ES01954229T priority patent/ES2311530T3/es
Priority to US10/332,946 priority patent/US20040068005A1/en
Priority to PCT/HU2001/000079 priority patent/WO2002005795A2/en
Priority to DE60134747T priority patent/DE60134747D1/de
Publication of HUP0002628A2 publication Critical patent/HUP0002628A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0002628A 2000-07-14 2000-07-14 Pharmaceutical combinations for treating diabetes HUP0002628A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
HU0002628A HUP0002628A2 (en) 2000-07-14 2000-07-14 Pharmaceutical combinations for treating diabetes
DE60134747T DE60134747D1 (de) 2000-07-14 2001-07-13 Pharmazeutische kombinationspräparate zur behandlung von diabetes mellitus
AT01954229T ATE400298T1 (de) 2000-07-14 2001-07-13 Pharmazeutische kombinationspräparate zur behandlung von diabetes mellitus
HU0700127A HU227386B1 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
AU2001276571A AU2001276571A1 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
CA002415392A CA2415392A1 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
EP01954229A EP1303304B1 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
JP2002511728A JP2004503585A (ja) 2000-07-14 2001-07-13 薬剤混合物
ES01954229T ES2311530T3 (es) 2000-07-14 2001-07-13 Combinaciones farmaceuticas para el tratamiento y la prevencion de la diabetes mellitus.
US10/332,946 US20040068005A1 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations
PCT/HU2001/000079 WO2002005795A2 (en) 2000-07-14 2001-07-13 Pharmaceutical combinations for treatment and prevention of diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0002628A HUP0002628A2 (en) 2000-07-14 2000-07-14 Pharmaceutical combinations for treating diabetes

Publications (2)

Publication Number Publication Date
HU0002628D0 HU0002628D0 (en) 2000-09-28
HUP0002628A2 true HUP0002628A2 (en) 2002-06-29

Family

ID=89978472

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002628A HUP0002628A2 (en) 2000-07-14 2000-07-14 Pharmaceutical combinations for treating diabetes

Country Status (10)

Country Link
US (1) US20040068005A1 (hu)
EP (1) EP1303304B1 (hu)
JP (1) JP2004503585A (hu)
AT (1) ATE400298T1 (hu)
AU (1) AU2001276571A1 (hu)
CA (1) CA2415392A1 (hu)
DE (1) DE60134747D1 (hu)
ES (1) ES2311530T3 (hu)
HU (1) HUP0002628A2 (hu)
WO (1) WO2002005795A2 (hu)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003249492A1 (en) * 2003-07-24 2005-02-14 Eswaran Krishnan Iyer Oral compositions for treatment of diseases
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
AU2005245240B2 (en) * 2004-05-20 2010-04-29 Scimar Ltd. Use of drug combinations for treating insulin resistance
CA2594407C (en) * 2005-02-11 2014-06-10 Nolabs Ab Device method, and use for treatment of neuropathy involving nitric oxide
WO2006084911A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Improved device for application of medicaments, manufacturing method therefor, and method of treatment
WO2006084910A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device and method for treatment of dermatomycosis, and in particular onychomycosis
EP1700611A1 (en) * 2005-02-11 2006-09-13 NOLabs AB Device for treatment of disorders in the oral cavity, and manufacturing process for the same
PL1871433T3 (pl) 2005-03-24 2009-09-30 Nolabs Ab Zabieg kosmetyczny z tlenkiem azotu, urządzenie do wykonywania tego zabiegu i sposób jego wytwarzania
JP5246833B2 (ja) * 2005-12-16 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生増強剤
JP5246834B2 (ja) * 2005-12-27 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生強化剤
ITPI20060103A1 (it) * 2006-08-07 2008-02-08 Univ Pisa Ibridi farmacodinamici con attivita' ipoglicemizzante e no-donor ottenuti dalla coniugazione di derivati idrossilati della glibenclamide con acidi carbossilici nitroossi-sostituiti.
WO2008080194A1 (en) * 2006-12-29 2008-07-10 The University Of Queensland Pain-relieving compositions and uses therefor
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
US8604081B2 (en) 2009-06-24 2013-12-10 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
JP6277124B2 (ja) 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド 局所用組成物
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
DK2854841T3 (en) 2012-06-04 2017-05-22 Diamedica Inc Kallikrein-1-glycosylation isoforms of human tissue
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9724419B2 (en) * 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US10206947B2 (en) 2013-08-08 2019-02-19 Novan, Inc. Topical compositions and methods of using the same
AU2014305778B2 (en) 2013-08-08 2019-11-21 Novan, Inc. Topical compositions and methods of using the same
WO2015031709A1 (en) * 2013-08-30 2015-03-05 Perosphere, Inc. Rapid acting injectable formulations comprising a peptide and a vasodilatory agent
ES2972423T3 (es) * 2015-07-28 2024-06-12 Lilly Co Eli Preparado farmacéutico para mejorar la absorción y la acción hipoglucemiante postprandial de la insulina
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
KR102426006B1 (ko) 2016-04-13 2022-07-29 노반, 인크. 감염 치료용 조성물, 시스템, 키트, 및 방법
JP2020510023A (ja) 2017-03-09 2020-04-02 ダイアメディカ， インコーポレイテッド 組織カリクレイン１の剤形
CN112920239B (zh) * 2019-12-05 2023-03-28 天津医科大学 α-葡萄糖苷酶诱导释放NO供体的制备及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
AU2282395A (en) * 1994-05-27 1995-12-21 Neptune Pharmaceutical Corporation Nitric oxide donor composition and method for treatment of anal disorders
US6190704B1 (en) * 1994-09-23 2001-02-20 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
US5906987A (en) * 1997-03-10 1999-05-25 Schering Aktiengesellschaft And Board Of Regents Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
WO1998043621A1 (en) * 1997-03-31 1998-10-08 The Children's Medical Center Corporation Nitrosylation to inactivate apoptotic enzymes
US20010056068A1 (en) * 1998-03-04 2001-12-27 Kristof Chwalisz Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives

Also Published As

Publication number Publication date
WO2002005795B1 (en) 2003-01-30
AU2001276571A1 (en) 2002-01-30
WO2002005795A3 (en) 2002-12-19
HU0002628D0 (en) 2000-09-28
DE60134747D1 (de) 2008-08-21
JP2004503585A (ja) 2004-02-05
WO2002005795A2 (en) 2002-01-24
ES2311530T3 (es) 2009-02-16
EP1303304A2 (en) 2003-04-23
CA2415392A1 (en) 2002-01-24
EP1303304B1 (en) 2008-07-09
ATE400298T1 (de) 2008-07-15
US20040068005A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
HUP0200556A3 (en) Medicament for treating diabetes
IL138784A0 (en) Treatment for diabetes
AU2001231104A1 (en) Methods for treating diabetes
GB0025473D0 (en) Pharmaceutical combinations
GB0020691D0 (en) Pharmaceutical combination
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
GB0031084D0 (en) Pharmaceutical compounds
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
GB0012291D0 (en) Pharmaceutical combination
EP1213021A4 (en) MEDICINE AGAINST DIABETES
GB0019272D0 (en) Pharmaceutical compounds
GB0024318D0 (en) Pharmaceutical compounds
HK1046133A1 (en) Pharmaceutical compounds.
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB0005366D0 (en) Pharmaceutical compounds
GB0021487D0 (en) Pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
GB0015079D0 (en) Solution for pharmaceutical use
GB0105595D0 (en) Pharmaceutical compounds
GB0031579D0 (en) Pharmaceutical compounds
GB0027678D0 (en) Pharmaceutical compounds
GB0022520D0 (en) Pharmaceutical compounds
GB0012534D0 (en) Pharmaceutical compounds
GB0002697D0 (en) Pharmaceutical solution

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: KERI PHARMA GENERICS KFT., HU

Free format text: FORMER OWNER(S): KERI PHARMA KFT., HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished